New York Assembly Bill A09119

New York 2025-2026 Regular Session

• Introduced: 9/26/25
• Refer: 9/26/25
• Refer: 1/7/26

Caption

Permits licensed pharmacists to prescribe and order certain medications for the purposes of inducing abortion or expelling a miscarriage after the completion of a risk assessment questionnaire and delivering a factsheet to the person to whom the medication is being disbursed.

Impact

The proposed bill aims to enhance the role of pharmacists within the healthcare system, especially regarding reproductive health. By permitting pharmacists to take on this responsibility, the bill may improve availability and access to abortion medication, which can often face barriers in traditional healthcare settings. It addresses a public health consideration aimed at ensuring that individuals seeking these medications can do so with sufficient guidance and evaluation of possible risks.

Summary

Bill A09119, introduced in the New York Assembly by M. of A. Paulin, seeks to expand the scope of practice for licensed pharmacists by allowing them to prescribe and order medications specifically for the purpose of inducing abortions or expelling miscarriages. This legislative proposal is a significant shift in pharmacy practice, aiming to improve access to reproductive healthcare services. As part of this authorization, pharmacists would be required to conduct a risk assessment and provide necessary informational materials to patients before dispensing such medications.

Contention

Despite its intentions, A09119 may face contention from various stakeholders. Supporters argue that enabling pharmacists to prescribe abortion medications will streamline access and reduce the need for multiple healthcare visits. However, opponents may raise concerns related to the safety and appropriateness of allowing pharmacists to handle such sensitive medical situations, as well as potential implications for patient counseling and care. These discussions may highlight broader debates around reproductive rights and healthcare access in New York.